Coherus Biosciences | Des Atouts

Assets Changement Date
AbbVie USD 136.22B 854M 2023-09
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
ALKERMES USD 2.28B 92.05M 2023-09
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amarin USD 839.03M 20.99M 2023-09
Amgen USD 97.15B 6.62B 2023-12
Baxter International USD 28.28B 2.38B 2023-12
Eli Lilly USD 57.92B 3.1B 2023-09
Fujifilm JPY 4.53T 152.38B 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
Ironwood Pharmaceuticals USD 471.07M 52.99M 2023-12
Myriad Genetics USD 1.15B 2.6M 2023-12
Pacira USD 1.57B 39.92M 2023-12
Perrigo USD 10.76B 206.4M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
PTC Therapeutics USD 1.9B 635.81M 2023-12
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Teva Pharmaceutical Industries USD 42.09B 1.01B 2023-09
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09
Xencor USD 952.69M 174.26M 2023-12
Zoetis USD 14.29B 180M 2023-12



Coherus Biosciences Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.